PepsiCo has posted a fall in full-year profits and sales as a 53rd week in 2011 results left a tough comparison. Net profits were down by 4% to US$6.18bn in 2012, the New York-based company said today (14 February). Net sales slipped by ...
Tags: PepsiCo, profits and sales, tough comparison
PepsiCo has booked a drop in first-quarter profits as restructuring costs weighed on earnings. Net profit in the three months to the end of March slid 1% to $1.13bn in the period, PepsiCo reported today (26 April). Reported EPS in the ...
Tags: PepsiCo, drop, first-quarter profits, restructuring costs, earnings
PTI reported that Essar Energy plc, an India focused integrated energy company, reported a 18% rise in core earnings in the 6 months ended September 30th 2012 on back of its British Stanlow refinery turnaround. The London listed firm said ...
The Hartford insurance has reported net income of $96m, or $0.18 per diluted share for the first quarter of 2012 against $501m, or $0.99 per diluted share, during the same period last year. According to the financial result released by ...
Tags: Hartford insurance, net income, core earnings, wealth management
The Hartford has reported net income of $401m, or $0.83 per diluted share, for the third quarter of 2012, against $60m, or $0.11 per diluted share, during the same period earlier year. Its core earnings grew to $378m, or $0.78 per diluted ...
Tags: Hartford, net income, third quarter, insurance, wealth management
Indorama Ventures Public Company Limited for the third quarter of 2012 achieved a consolidated sales of US$ 1,697 million (Baht 53,249 million), consolidated reported EBITDA of US$ 122 million (Baht 3,818 million), consolidated net profit ...
GlaxoSmithKline (GSK) has signed a definitive agreement to acquire Human Genome Sciences (HGS) for $14.25 per share in cash. The transaction values HGS at approximately $3.6bn on an equity basis, or approximately $3bn net of cash and ...
Tags: GSK, Human Genome Sciences, HGS